Global Thromboelastography Analyzer Market Outlook 2022

Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation. It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in Emergency Departments, intensive care units, and labor and delivery suites. More common tests of blood coagulation include prothrombin time (PT) and partial thromboplastin time (aPTT) which measure coagulation factor function, but TEG also can assess platelet function, clot strength, and fibrinolysis which these other tests cannot. Thromboelastography Analyzer provides rapid, comprehensive and accurate identification of an individual's hemostasis condition in a laboratory or point-of-care setting.
The key players of Thromboelastography Analyzer include Haemonetics, WerfenLife, Framar Hemologix srl, Sienco, etc. The top two players of Thromboelastography Analyzer account for approximately 72% of the total market. North America is the largest market of Thromboelastography Analyzer accounting for about 33%, followed by Europe and Asia Pacific. In terms of Type, Conduit Techniques is the largest segment, with a share about 62%. In terms of Application, the largest segment is Hospital, followed by Maternal and Child Health Service.

The global Thromboelastography Analyzer market was valued at US$ 244.2 million in 2020 and is expected to reach US$ 578.1 million by the end of 2027, growing at a CAGR of 12.8% during 2021-2027.
This report focuses on Thromboelastography Analyzer volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Thromboelastography Analyzer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Thromboelastography Analyzer Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Single and Double Channel
Four Channels
Others

Segment by Application
Hospital
Maternal and Child Health Service
Laboratory
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Framar Hemologix srl
Sienco

Frequently Asked Questions